Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Leff

Showing results (161-170 of 168) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 168 results.
Open Forum Infectious Diseases|May 9, 2017
Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1Benjamin P Linas, Jake R Morgan, Mai T Pho, et al.
The Journal of Allergy and Clinical Immunology|September 14, 1999
Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. Montelukast/Salmeterol Exercise Study GroupC Villaran, S J O'Neill, A Helbling, et al.
Current Medical Research and Opinion|January 6, 2006
Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) studyAllan Gibofsky, William R Palmer, John A Goldman, et al.
BMC Health Services Research|March 25, 2017
The structural and health policy environment for delivering integrated HIV and substance use disorder treatments in Puerto RicoJared A Leff, Diana Hernández, Paul A Teixeira, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Cost-Effectiveness of One-Time Hepatitis C Screening Strategies Among Adolescents and Young Adults in Primary Care SettingsSabrina A Assoumou, Abriana Tasillo, Jared A Leff, et al.
Annals of Internal Medicine|March 31, 2015
The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infectionBenjamin P Linas, Devra M Barter, Jake R Morgan, et al.
Health & Justice|September 23, 2018
Criminal justice measures for economic data harmonization in substance use disorder researchKathryn E McCollister, Xuan Yang, Sean M Murphy, et al.
The European Respiratory Journal|December 10, 2015
Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trialsPaul W Noble, Carlo Albera, Williamson Z Bradford, et al.
Pageof 17

Showing results (161-170 of 168) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 168 results.
Open Forum Infectious Diseases|May 9, 2017
Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1Benjamin P Linas, Jake R Morgan, Mai T Pho, et al.
The Journal of Allergy and Clinical Immunology|September 14, 1999
Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. Montelukast/Salmeterol Exercise Study GroupC Villaran, S J O'Neill, A Helbling, et al.
Current Medical Research and Opinion|January 6, 2006
Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) studyAllan Gibofsky, William R Palmer, John A Goldman, et al.
BMC Health Services Research|March 25, 2017
The structural and health policy environment for delivering integrated HIV and substance use disorder treatments in Puerto RicoJared A Leff, Diana Hernández, Paul A Teixeira, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Cost-Effectiveness of One-Time Hepatitis C Screening Strategies Among Adolescents and Young Adults in Primary Care SettingsSabrina A Assoumou, Abriana Tasillo, Jared A Leff, et al.
Annals of Internal Medicine|March 31, 2015
The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infectionBenjamin P Linas, Devra M Barter, Jake R Morgan, et al.
Health & Justice|September 23, 2018
Criminal justice measures for economic data harmonization in substance use disorder researchKathryn E McCollister, Xuan Yang, Sean M Murphy, et al.
The European Respiratory Journal|December 10, 2015
Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trialsPaul W Noble, Carlo Albera, Williamson Z Bradford, et al.
Pageof 17